Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:10:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. No visible changes to the study page content or its functionality are evident.
    Difference
    0.0%
    Check dated 2026-03-12T01:45:55.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. Outdated funding lapse notices and operating-status messages tied to earlier revisions (v3.4.1) were removed.
    Difference
    0.2%
    Check dated 2026-02-11T14:11:48.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a government funding notice regarding operations and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:22:20.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Additions: Show glossary UI element; new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. Deletions: remove 'Last Update Submitted that met QC Criteria' (lowercase 'met'), 'No FEAR Act data', and the older Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T06:11:19.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 updated on the page, replacing v3.3.3. This appears to be a non-substantive, cosmetic update that does not alter study details or eligibility.
    Difference
    0.0%
    Check dated 2026-01-14T03:29:36.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.